The Healthcare Property Company (HPC) announces that Ray Stanbridge has joined the board of the company’s parent, The Healthcare Property Group (HPG), to support its ambitious growth plans.
Ray, who is founding partner of Stanbridge Associates, a specialist accountancy and tax advisory practice for medical consultants and private hospitals, has joined HPG as a non-executive director, joining on the board Paul Stacey, the founder and managing director, and Victoria Stacey, director.
The appointment of Ray will support HPC’s new focus on the development of healthcare facilities for the private sector. Historically, HPC has worked predominantly with the NHS in developing a range of facilities in primary care. It has also developed polyclinics in Germany. Its move to working with the private sector was established four years ago when it partnered with IVF pioneer, Bourn Hall. HPC is now exploring a range of opportunities in the private sector, although because of its extensive experience of working with NHS providers it will continue to look for opportunities in the public sector.
HPC is wholly owned by Paul Stacey, who has an impressive 40-year record in the healthcare sector, including almost 20 years with Nuffield Hospitals and since has been instrumental in the development of a number of innovative healthcare services. His daughter Victoria Stacey, having had over 10 years’ experience in the healthcare industry working on several projects, is a director at the company. Victoria project managed the development of the full-service fertility clinic for Bourn Hall in Wickford, Essex, which culminated in a successful investment sale process. The father and daughter team, along with support staff, pride themselves on excellent client care, and attention to detail on projects.
HPC Managing Director, Paul Stacey, said: “Ray’s appointment to the HPG board begins an exciting new period for us, as we engage more extensively with private sector operators and stakeholders. He has an impressive wealth of knowledge and experience in the private healthcare sector which will support our new strategy”.
